Center for Health Systems Innovation

Medicine & Life Sciences

1. Systematic Reviews 100%
2. Meta-Analysis 72%
3. Fimbriae Proteins 57%
4. Electronic Health Records 51%
5. Smokers 48%
6. Machine Learning 43%
7. Primary Health Care 43%
8. Smoking Cessation 42%
9. Cross-Sectional Studies 41%
10. Veterans 40%
11. Psoriasis 38%
12. Physicians 35%
13. Sepsis 31%
14. Data Mining 29%
15. Workload 28%
16. Delivery of Health Care 28%
17. Escherichia coli K12 26%
18. Patient Protection and Affordable Care Act 26%
19. Decision Trees 26%
20. Systemic Inflammatory Response Syndrome 26%
21. Pneumocystis carinii 25%
22. Postoperative Nausea and Vomiting 24%
23. Health 24%
24. Workflow 23%
25. Diltiazem 23%
26. Achilles Tendon 23%
27. Dry Eye Syndromes 23%
28. Vietnam 23%
29. Membranes 23%
30. Nephrology 23%
31. Digoxin 22%
32. Diabetic Neuropathies 22%
33. Patient Readmission 22%
34. Primary Care Physicians 22%
35. Hormone Replacement Therapy 21%
36. Delayed Hypersensitivity 21%
37. Automobiles 21%
38. Hospital Emergency Service 20%
39. Hospital Mortality 20%
40. Diabetic Retinopathy 20%
41. MEDLINE 20%
42. Spouses 19%
43. Type 2 Diabetes Mellitus 19%
44. Pharmacology 19%
45. Arousal 19%
46. Support Vector Machine 18%
47. Early Detection of Cancer 18%
48. Efficiency 17%
49. Atrial Fibrillation 17%
50. Chronic Obstructive Pulmonary Disease 17%
51. Odds Ratio 16%
52. Rupture 16%
53. Mortality 16%
54. Single Nucleotide Polymorphism 16%
55. Coronary Artery Disease 16%
56. Quality of Life 15%
57. Randomized Controlled Trials 15%
58. Comorbidity 15%
59. Peptides 14%
60. Heart Rate 14%
61. Medicaid 14%
62. Armed Conflicts 13%
63. Datasets 13%
64. Therapeutics 13%
65. Cohort Studies 13%
66. Workforce 13%
67. Pediatrics 12%
68. Breast Neoplasms 12%
69. Confidence Intervals 12%
70. Logistic Models 11%
71. Transportation of Patients 11%
72. Organizational Efficiency 10%
73. Fluticasone-Salmeterol Drug Combination 9%
74. Myocardial Ischemia 9%
75. Wounds and Injuries 9%
76. Quality Improvement 9%
77. Formoterol Fumarate 9%
78. Conjugated (USP) Estrogens 8%
79. Marital Status 8%
80. Medicare 8%
81. Budesonide 8%
82. T-Lymphocyte Subsets 8%
83. Sample Size 8%
84. Pharmaceutical Preparations 8%
85. United States Health Resources and Services Administration 7%
86. Area Under Curve 7%
87. Research Personnel 7%
88. Smoking 7%
89. Coronary Disease 7%
90. Databases 7%
91. Proteins 7%
92. Healthcare Disparities 6%
93. Lyt antibodies 6%
94. Alkaline Phosphatase 6%
95. Clinical Decision-Making 6%
96. Urban Hospitals 6%
97. Amino Acids 6%
98. Fluorescein 6%
99. Length of Stay 6%
100. Health Literacy 5%